At the time of writing, Biodesix Inc [BDSX] stock is trading at $0.4, down -10.40%. An important factor to consider is whether the stock is rising or falling in short-term value. The BDSX shares have gain 10.27% over the last week, with a monthly amount glided 31.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biodesix Inc [NASDAQ: BDSX] stock has seen the most recent analyst activity on May 14, 2025, when William Blair downgraded its rating to a Mkt Perform. On July 26, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $3 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $2.80 on May 13, 2024. Lake Street initiated its recommendation with a Buy and recommended $3 as its price target on May 03, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 17, 2021, and downed its price target to $11. In a note dated November 23, 2020, William Blair initiated an Outperform rating.
For the past year, the stock price of Biodesix Inc fluctuated between $0.17 and $2.04. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Biodesix Inc [NASDAQ: BDSX] shares were valued at $0.4 at the most recent close of the market. An investor can expect a potential return of 650.0% based on the average BDSX price forecast.
Analyzing the BDSX fundamentals
According to Biodesix Inc [NASDAQ:BDSX], the company’s sales were 76.56M for trailing twelve months, which represents an 11.68% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at -0.44%, Pretax Profit Margin comes in at -0.54%, and Net Profit Margin reading is -0.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -1.68 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of5.63.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Biodesix Inc [NASDAQ:BDSX] has a current ratio of 2.14. On the other hand, the Quick Ratio is 2.03, and the Cash Ratio is 1.32. Considering the valuation of this stock, the price to sales ratio is 0.77, the price to book ratio is 51.61.
Transactions by insiders
Recent insider trading involved SCHULER JACK W, Director, that happened on May 16 ’25 when 4.0 million shares were purchased. Director, SCHULER JACK W completed a deal on May 19 ’25 to buy 0.72 million shares. Meanwhile, Chief Accounting Officer Vazquez Chris sold 112.0 shares on May 12 ’25.
